Skip to main content
Student homeNews home
Story

UC’s commercialization navigator pilots tech transfer at 1819 Innovation Hub

Housed within the University of Cincinnati’s 1819 Innovation Hub, the Technology Transfer team is vital to safeguarding and managing the intellectual property generated by UC’s researchers. Its mission is to translate UC's cutting-edge innovations into viable technologies by evaluating patentability and commercial viability, ensuring compliance and legal protection, recruiting and maintaining external partners, marketing technologies, negotiating license deals and identifying funding opportunities. This multifaceted approach ensures that groundbreaking discoveries from UC are positioned to reach the market, delivering substantial benefits that impact society.

In May 2023, Technology Transfer recruited Patrick Brown from UC’s College of Engineering and Applied Science to fill this position. The role isn’t new territory for Brown. Throughout his career, he has been passionate about translational research and the importance of understanding external partners’ needs. This is a learning he has carried over to his position as commercialization navigator.

Since joining, Brown has significantly expanded UC’s network of potential partners and his impact has been immediate, especially in the human health and life sciences sectors.

Technologies developed in the life sciences sector in key areas such as pharmaceuticals, medical devices, diagnostics and vaccines can deliver potentially transformative breakthroughs to improve health care outcomes. The field is supported by a robust ecosystem of funding from government organizations, foundations, venture capital firms and corporations and is crucial to bolstering the nation's competitive edge in the global biotech landscape.

Institutions of higher learning are pivotal players in shaping the future of biotechnology through cutting-edge research, technology development and intellectual property, as well as robust commercialization ecosystems and initiatives.

Brown recently attended the BIO International Convention in San Diego, California. More than 18,500 industry leaders from pharmaceutical companies, academia, biotech startups and investment firms networked with other biotech professionals, exploring potential collaborations and relationship-building to propel initiatives forward.

UC’s participation in this event signals a significant investment by the institution in promoting awareness of UC’s contributions to life sciences, building an ecosystem of potential partners and accelerating the advancement and commercialization of university technologies in this space.

"At UC, we are constantly pushing the boundaries of knowledge. The discoveries and patented technologies from our researchers act as essential catalysts, fostering the exchange of ideas that drive biotechnology innovation," Brown said. "During the conference, through a peer-to-peer partnering platform, I was able to connect with key business development personnel from pharmaceutical companies of all sizes, startups and venture capital firms. This has significantly broadened our network and created new opportunities for bringing our technologies to the market."

Latest UC News